CGON
CG Oncology, Inc.
67.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -200.0% | – | +75.0% | +200.0% | -100.0% | – | +550.0% | +166.7% | +104.1% | -0.9% | +1.1% | – | |
| – | +97.5% | +95.0% | +48.1% | +17.9% | +88.4% | +3.2% | +36.0% | +4.6% | -2.0% | -9.9% | +121.4% | – | |
| – | +1,008.7% | -488.5% | – | +13.1% | +43.9% | -90.4% | +1,747.1% | -133.2% | – | – | – | – | |
| – | -100.0% | – | +16.7% | -92.9% | +20,800.0% | -92.3% | -12.5% | +592.9% | -92.8% | +4,242.9% | +53.9% | – | |
| – | – | -1,914.6% | -88.2% | – | -65.9% | -1,812.7% | – | +969.3% | -601.9% | +343.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -102.7% | – | -100.0% | +5,317.5% | +10,209.8% | -99.8% | -165.8% | – | +82.2% | +296.7% | -99.5% | – | |
| – | – | – | -175.6% | – | +1,070.5% | -200.9% | – | – | -141.5% | – | -1,262.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.